:

SOFTBANK PLANS $100B AI ROBOTICS IPO

AI DESK2 MIN READ
THU, APR 30, 2026

■ AI-SUMMARIZED FROM 5 SOURCES ▸ TIMELINE

SoftBank Group plans to establish and publicly list Roze, a standalone AI and robotics company focused on data centers, as early as 2026 with a $100 billion valuation target.

The Japanese conglomerate is moving forward with its strategy to spin off and capitalize on artificial intelligence infrastructure, according to sources cited by the Financial Times. Roze will operate as a separate entity building and managing data centers specifically designed for AI workloads. The company represents SoftBank's effort to attract investor capital in the booming AI infrastructure sector, where demand for computing power continues to surge. SoftBank chief Masayoshi Son has been actively pursuing the company's presence in AI and robotics. The IPO timing of 2026 or potentially earlier signals the company's confidence in market conditions and investor appetite for specialized AI infrastructure plays. The $100 billion valuation target reflects the high valuations commanded by data center and AI infrastructure companies. Comparable firms in the space have seen significant investor interest as enterprises race to build out their AI capabilities. This move aligns with broader trends among major technology companies to create standalone units for high-growth segments. By operating Roze as an independent publicly traded entity, SoftBank can provide dedicated focus and capital structures tailored to the data center and robotics markets. The timing and specifics remain subject to market conditions and regulatory approvals. SoftBank has not made an official announcement, and details could shift as planning continues. The move underscores how artificial intelligence infrastructure has become a critical business focus for major technology and investment firms seeking exposure to the sector's growth trajectory.

■ SOURCES

Bloomberg TechTechmemeTechmemeTechmemeTechmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

15H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

15H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

22H AGOAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.